COAGULATION ANALYZERS MARKET ANALYSIS

Market Challenges And Opportunities

Handheld Coagulation analyzers and their strips are easy-to-use tools and pose a low risk of hazard during discard, however, these devices are not error-proof. Although,  the results obtained by these devices may not be as specific and sensitive as that offered by the centralized laboratory results. Moreover, optimization of a few tests may differ from one device to another. Thus, just as test results may not be consistent from one laboratory to another, there may be variation in the data obtained through the use of different devices, which is a major factor hampering growth of the coagulation analyzers market.

Manufacturers are focusing on new product launches strategy, which is a prominent factor fueling the market growth

Manufacturers in various regions are focusing on enhancing their market share by creating awareness about its products through various events and introducing new products, along with existing range. In November 2016, Alere supported the Point-of-Care Day event, in which clinicians from across Latin America gathered in Sao Paulo, Brazil to showcase the benefits and best practices in point-of-care testing and encourage its use. Competitors in the coagulation analyzers market are also focused on new product development to enhance its product offerings and market share. For instance, in August 2016, Instrumentation Laboratory commercialized a new prothrombin reagent-HemosIL ReadiPlasTin, in order to expand the company’s broad portfolio of liquid, ready-to-use reagents to help laboratories achieve greater efficiency, while improving patient care.